4D Molecular Therapeutics Inc
FDMT
Company Profile
Business description
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
Contact
5858 Horton Street
Suite 455
EmeryvilleCA94608
USAT: +1 510 505-2680
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
227
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,806.40 | 64.50 | 0.74% |
| CAC 40 | 7,791.47 | 13.40 | -0.17% |
| DAX 40 | 24,174.32 | 130.14 | -0.54% |
| Dow JONES (US) | 42,761.76 | 1.11 | -0.00% |
| FTSE 100 | 8,832.28 | 5.63 | -0.06% |
| HKSE | 24,232.49 | 51.06 | 0.21% |
| NASDAQ | 19,591.24 | 61.28 | 0.31% |
| Nikkei 225 | 38,473.97 | 385.40 | 1.01% |
| NZX 50 Index | 12,572.34 | 33.08 | 0.26% |
| S&P 500 | 6,005.88 | 5.52 | 0.09% |
| S&P/ASX 200 | 8,581.20 | 65.50 | 0.77% |
| SSE Composite Index | 3,404.24 | 4.47 | 0.13% |